Search Results - Markus Rechsteiner

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Histologic and Molecular Patterns in Responders and Non-responders With Chronic-Active Antibody-Mediated Rejection in Kidney Transplants by Onur Sazpinar, Ariana Gaspert, Daniel Sidler, Markus Rechsteiner, Thomas F. Mueller

    Published in Frontiers in Medicine (2022-04-01)
    Get full text
    Article


  2. 2

    Establishment and Validation of Patient-Derived Non-Small Cell Lung Cancer Organoids as In Vitro Lung Cancer Models by Raphael S. Werner, Jae-Hwi Jang, Markus Rechsteiner, Michaela B. Kirschner, Isabelle Opitz

    Published in Organoids (2024-11-01)
    Get full text
    Article


  3. 3

    Targeting ALK in Neuroendocrine Tumors of the Lung by Dilara Akhoundova, Dilara Akhoundova, Dilara Akhoundova, Martina Haberecker, Ralph Fritsch, Sylvia Höller, Michael K. Kiessling, Michael K. Kiessling, Markus Rechsteiner, Jan H. Rüschoff, Alessandra Curioni-Fontecedro

    Published in Frontiers in Oncology (2022-06-01)
    Get full text
    Article


  4. 4

    p53 suppresses type II endometrial carcinomas in mice and governs endometrial tumour aggressiveness in humans by Peter J. Wild, Kristian Ikenberg, Thomas J. Fuchs, Markus Rechsteiner, Strahil Georgiev, Niklaus Fankhauser, Aurelia Noske, Matthias Roessle, Rosmarie Caduff, Athanassios Dellas, Daniel Fink, Holger Moch, Wilhelm Krek, Ian J. Frew

    Published in EMBO Molecular Medicine (2012-06-01)
    Get full text
    Article


  5. 5

    Acquired resistance to anti-PD1 therapy in patients with NSCLC associates with immunosuppressive T cell phenotype by Stefanie Hiltbrunner, Lena Cords, Sabrina Kasser, Sandra N. Freiberger, Susanne Kreutzer, Nora C. Toussaint, Linda Grob, Isabelle Opitz, Michael Messerli, Martin Zoche, Alex Soltermann, Markus Rechsteiner, Maries van den Broek, Bernd Bodenmiller, Alessandra Curioni-Fontecedro

    Published in Nature Communications (2023-08-01)
    Get full text
    Article


Search Tools: